Welcome to the new Regeneron Newsroom. This newsroom is designed to provide members of the media with easy access to up-to-date information about the Company.
For an e-mail response to questions about Regeneron, please contact us at media@regeneron.com .
Upcoming Events
May 29, 2013
38th Annual dbAccess Healthcare Conference
Jun 3, 2013
Jun 11, 2013
Goldman Sachs 34th Annual Global Healthcare Conference
Jun 14, 2013
Regeneron Annual Shareholders Meeting
May 15, 2013
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
May 8, 2013
Regeneron Announces Upcoming 2013 Investor Conference Presentations
May 3, 2013
Regeneron Reports First Quarter 2013 Financial and Operating Results
May 3, 2013
Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs
Apr 18, 2013
Regeneron Announces Upcoming 2013 Investor Conference Presentations
Apr 11, 2013
Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013
Apr 4, 2013
Regeneron Pharmaceuticals Announces Expansion in New York's Hudson Valley
Mar 4, 2013
Regeneron Announces Potential Additional Royalty Stream Related to EU Approval for Ilaris® (canakinumab) in Patients Suffering Acute Gouty Arthritis Attacks Who Cannot Gain Relief From Current Treatments
Mar 2, 2013
Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
Feb 19, 2013
Regeneron Announces Upcoming 2013 Investor Conference Presentations
Shareholder Briefcase
E-mail Alerts
Download Library
REGN Snapshot
RSS News Feeds
Jefferies 2013 Healthcare Conference
